Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Older Adults Accept Dementia Telephone Screening

By HospiMedica International staff writers
Posted on 10 May 2015
Nearly two-thirds of older adults in the United States are willing to undergo telephone screening for dementia, according to a new study.

Researchers from Indiana University (Bloomington, IN, USA) and the Regenstrief Institute (Indianapolis, IN, USA) conducted a phone survey of 400 older primary care patients on their perceptions of the risks and benefits of dementia screening, and to measure the association between attitudes and actual screening behaviors. More...
Eligible patients completed the Perceptions Regarding Investigational Screening for Memory in Primary Care (PRISM-PC) questionnaire, and were then asked to undergo dementia screening by telephone.

The results pointed to a 63.7% willingness to be screened by phone for dementia, regardless of sex, age, or race. The two most significant predictors of willingness to be screened by phone were belief in benefits of early knowledge of cognitive decline, and having a friend or relative with Alzheimer's disease (AD). Participants who refused screening were also less likely to agree on screening for other conditions, such as depression and cancer. The study was published on April 6, 2015, in the Journal of Aging Research.

“Despite rising incidence rates of Alzheimer's and other dementias, many individuals with cognitive impairment are not screened. They go unrecognized and thus never receive evaluation or diagnosis,” said lead author Nicole Fowler, PhD, and colleagues of the Indiana University Center for Aging Research. “Understanding patients' attitude about the risk and benefits of early identification of dementia is vital as we evaluate potential screening barriers and facilitators.”

Dementia is an overall term for the wide range of symptoms associated with a decline in memory or other cognitive skills severe enough to reduce a person's ability to perform everyday activities. The incidence of dementia is growing globally, with a new patient being diagnosed approximately every 7 seconds. It is estimated that by 2050 there will be 11–19 million people in the USA alone living with dementia, of which AD, a progressive condition, is the most common form.

Related Links:

Indiana University
Regenstrief Institute



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.